ZIOPHARM Oncology Announces Filing of Resale Registration Statement for Previous Private Placement
ZIOPHARM Oncology Announces Filing of Resale Registration Statement for Previous Private Placement
ZIOPHARM Oncology, Inc. announced today that on May 18, 2011 it filed a resale registration statement on Form S-3 with the United States Securities and Exchange Commission . The registration statement registers for resale common shares issued or issuable to Intrexon Corporation in a private placement under a Stock Purchase Agreement with Intrexon dated January 6, 2011.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Information Tags: Announces, Filing, Oncology, Placement, Previous, private, Registration, Resale, Statement, ZIOPHARM
Lorus Therapeutics Announces Allowance of United States Patent for Cancer Drug LOR-2040 in the Treatment of Acute …
Lorus Therapeutics Announces Allowance of United States Patent for Cancer Drug LOR-2040 in the Treatment of Acute …
TORONTO, ONTARIO– – Lorus Therapeutics Inc. , a biopharmaceutical company specializing in the discovery, research and development of pharmaceutical products and technologies for the management of cancer, today announced that the United States Patent and Trademark Office has allowed a new patent for the Company’s lead clinical stage cancer drug LOR-2040 in the treatment of Acute Myeloid Leukemia .
Read more on CCNMatthews via Yahoo! Finance
Categories: Breast Cancer Information Tags: acute, Allowance, Announces, cancer, drug, LOR2040, Lorus, Patent, States, Therapeutics', Treatment, United
OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase 1 Testing of Anti-Cancer Stem Cell Therapeutic OMP …
OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase 1 Testing of Anti-Cancer Stem Cell Therapeutic OMP …
REDWOOD CITY, Calif., April 28, 2011 /PRNewswire/ — OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells or tumor-initiating cells, today announced that the FDA has accepted an IND filing for OMP-18R5, which allows OncoMed to commence Phase 1 clinical testing. OMP-18R5 is a monoclonal antibody that binds selected receptors in the Wnt signaling …
Read more on redOrbit
Categories: Breast Cancer Information Tags: Announces, Anticancer, Cell, Clearance, Commence, OncoMed, Pharmaceuticals, Phase, Stem, testing, Therapeutic
iCAD Announces New Chief Financial Officer Kevin Burns
iCAD Announces New Chief Financial Officer Kevin Burns
NASHUA, N.H.–(BUSINESSWIRE)– iCAD, Inc. , an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announced today that Kevin …
Read more on Business Wire Finance Press Releases UK via Yahoo! UK & Ireland Finance
Mediasmith Announces New NYC Clients: Breastcancer.org and Touch of Fabulous
Mediasmith Announces New NYC Clients: Breastcancer.org and Touch of Fabulous
The good news continues to roll in for digital media agency, Mediasmith. Â In conjunction with the opening of their New York City office, announced earlier in February, Mediasmith has acquired two new clients: the non-profit organization, Breastcancer.org and Touch of Fabulous, an online luxury consumer goods business offering personal shopping services.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Information Tags: Announces, Breastcancer.org, Clients, Fabulous, Mediasmith, touch